中国介入心脏病学杂志2024,Vol.32Issue(4) :232-235.DOI:10.3969/j.issn.1004-8812.2024.04.009

经导管主动脉瓣置换术后房性心动过速射频消融1例

Radiofrequency ablation on prosthetic valve for atrial tachycardia after transcatheter aortic valve replacement

李红校 黄碧君 王路鑫 王兴旭 汪云开 何晓燕 张建强
中国介入心脏病学杂志2024,Vol.32Issue(4) :232-235.DOI:10.3969/j.issn.1004-8812.2024.04.009

经导管主动脉瓣置换术后房性心动过速射频消融1例

Radiofrequency ablation on prosthetic valve for atrial tachycardia after transcatheter aortic valve replacement

李红校 1黄碧君 1王路鑫 1王兴旭 1汪云开 1何晓燕 1张建强1
扫码查看

作者信息

  • 1. 同济大学附属东方医院心血管内科 心律失常教育部重点实验室,上海 200120
  • 折叠

摘要

经导管主动脉瓣置换术(TAVR)作为主动脉瓣病变的治疗新选择,显示出广阔的应用前景.但随之而来的是,TAVR术后快速型心律失常问题逐渐凸显,备受医学界关注.当前,药物治疗是处理TAVR相关房性心律失常的主流方法,而导管消融的治疗潜力尚待进一步探索.特别是当心律失常病灶与人工瓣膜紧密相关时,消融术的实际应用效果与安全性还有待验证.近期,同济大学附属东方医院成功为1例具有此类复杂病症的患者实施了射频消融术,初步探索了在人工瓣膜表面实施导管消融术的有效性和安全性.

Abstract

Transcatheter aortic valve replacement(TAVR)has emerged as a promising therapeutic alternative for addressing aortic valve-related pathologies.However,the occurrence of rapid arrhythmias linked to TAVR procedures is progressively drawing scrutiny.Presently,pharmacologic interventions constitute the mainstay of managing atrial arrhythmias related to TAVR,while the potential of ablation as a viable treatment modality remains undefined.Notably,in cases where the arrhythmia's genesis is presumed to be intricately linked to the prosthetic valve,the practicality and safety of ablation procedures remain unverified.Our institution has successfully ventured into radiofrequency ablation for a distinctive patient presenting with this intricate condition,thereby tentatively affirming the efficacy and safety of catheter ablation administered on the surface of prosthetic valves.

关键词

经导管主动脉瓣置换术/房性心动过速/射频消融

Key words

Transcatheter aortic valve replacement/Atrial tachycardia/Radiofrequency ablation

引用本文复制引用

基金项目

浦东新区临床高峰学科建设项目(PWYgf2021-01)

上海市浦东新区卫生系统重点学科群建设项目(PWZxq2022-02)

出版年

2024
中国介入心脏病学杂志
北京大学

中国介入心脏病学杂志

CSTPCDCSCD
影响因子:1.224
ISSN:1004-8812
参考文献量2
段落导航相关论文